Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
1,100.611,106.151,114.281,098.89
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
612.30612.30616.40612.30
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
1,175.461,182.971,193.951,182.97
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
1,729.121,731.371,754.071,718.58
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
644.73645.31649.16642.15
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
827.09828.05833.90827.27
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
214.82214.82216.61212.62
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
3,115.173,142.773,186.203,133.07
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
910.43915.18923.94906.03
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
1,474.501,480.841,491.461,475.55
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
2,405.872,415.572,420.792,398.99
ZBIO:NASDAQ
Zenas Biopharma Inc
$20.07
-1.81%
(-0.37) 1D
$20.07
0.00% (0.00)
After hours
Closed: Apr 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZBIO...
Open
$20.67
High
$21.12
Low
$19.66
Mkt. cap
1.19B
Avg. vol.
842.87K
Volume
507.48K
52-wk high
$44.60
52-wk low
$8.51
EPS
-$8.44
Shares outstanding
57.36M
No. of employees
167
News stories
From sources across the web
About Zenas Biopharma Inc
CEO-
Employees167
Founded2019
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Last report
Mar 16, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-4.54/ (-1.19 est.)USD
-281.51%miss
Revenue / Estimate
0.00/ (28.75M est.)USD
0.00%miss
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
10.00M
-
-
-
Cost of goods sold
34.92M
43.03M
34.40M
-112.34M
Cost of revenue
34.92M
43.03M
34.40M
-112.34M
Research and development expenses
-
-
-
168.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.42M
12.14M
13.18M
15.59M
Operating expense
12.42M
12.14M
13.18M
183.66M
Total operating expenses
47.33M
55.16M
47.58M
71.31M
Operating income
-37.33M
-55.16M
-47.58M
-71.31M
Other non operating income
3.55M
2.96M
1.08M
-7.48M
EBT including unusual items
-33.78M
-52.20M
-51.50M
-240.34M
EBT excluding unusual items
-33.78M
-52.20M
-46.50M
-73.66M
Income tax expense
-205.00K
20.00K
-
106.00K
Effective tax rate
0.61%
-0.04%
-
-0.04%
Other operating expenses
-
-
-
-
Net income
-33.57M
-52.22M
-51.50M
-240.44M
Net profit margin
-335.73%
-
-
-
Earnings per share
-0.80
-1.25
-1.22
-1.39
Interest and investment income
-
-
-
12.15M
Interest expense
-
-
-
-7.33M
Net interest expenses
-
-
-
4.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
-37.31M
-55.15M
-47.57M
-71.30M
Gain or loss from assets sale
107.00K
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more